> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-183/
- Published: 2018-06-10T12:00:00.000Z
- Updated: 2026-09-15T00:12:01.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141651

[**Mutamycin Not Withdrawn Over Safety/Efficacy: FDA**](http://www.fdaweb.com/login.php?sa=v&aid=D5141646&cate=FR&stid=%241%24dS0.i2%2F.%24EMBah0IfISI3bZh5eTLC7.)  
*Federal Register* notice: FDA determines that Mutamycin (mitomycin) injectable, 5mg/vial and 20mg/vial, was not withdrawn for reasons of safety or effectiveness. 06/11/2018 

[**Correction on Product Classification Proposed Rule**](https://www.fdaweb.com/correction-on-product-classification-proposed-rule/)  
*Federal Regis*ter notice: FDA corrects a 5/15 proposed rule to amend its regulations concerning the classification of products as biological products, devices, drugs, or combination products. 06/08/2018

[**FDA Workshop on Developing Inhaled Antibacterial Drugs**](https://www.fdaweb.com/fda-workshop-on-developing-inhaled-antibacterial-drugs/)  
*Federal Register* notice: FDA announces a 6/27 public workshop entitled “Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis.” 06/08/2018

[**Intramedullary Fixation Rod Placed Into Class 2**](https://www.fdaweb.com/intramedullary-fixation-rod-placed-into-class-2/)  
*Federal Register* notice: FDA classifies the in vivo cured intramedullary fixation rod into Class 2 (special controls). 06/08/2018

[**Info Collection Extension Sought for Device eMDR Submissions**](https://www.fdaweb.com/info-collection-extension-sought-for-device-emdr-submissions/)  
*Federal Register* notice: FDA submits a proposed extension for a collection of information on Medical Device Reporting: Electronic Submission Requirements. 06/08/2018

[**Modifications to FDA Recognized Consensus Standards**](https://www.fdaweb.com/modifications-to-fda-recognized-consensus-standards/)  
*Federal Register* notice: FDA publishes modifications to its list of standards the agency recognizes for use in premarket reviews (FDA Recognized Consensus Standards). 06/07/2018

[**Panel to Review GSK COPD Add-on Therapy**](https://www.fdaweb.com/panel-to-review-gsk-copd-add-on-therapy/)  
*Federal Register* notice: FDA announces a 7/25 Pulmonary-Allergy Drugs Advisory Committee meeting. 06/06/2018

[**Sun Pharma Not Withdrawing Benazepril HCl/Hydrochlorothiazide**](https://www.fdaweb.com/sun-pharma-not-withdrawing-benazepril-hcl-hydrochlorothiazide/)  
*Federal Register* notice: FDA corrects a 2/23 notice announcing that Sun Pharmaceutical Industries asked to withdraw its generic benazepril hydrochloride and hydrochlorothiazide tablets. 06/06/2018